TRIM59 overexpression correlates with poor prognosis and contributes to breast cancer progression through AKT signaling pathway.

MLA

Liu, Yunxiao, et al. “TRIM59 Overexpression Correlates with Poor Prognosis and Contributes to Breast Cancer Progression through AKT Signaling Pathway.” Molecular Carcinogenesis, vol. 57, no. 12, Dec. 2018, pp. 1792–802. EBSCOhost, https://doi.org/10.1002/mc.22897.

APA

Liu, Y., Dong, Y., Zhao, L., Su, L., Diao, K., & Mi, X. (2018). TRIM59 overexpression correlates with poor prognosis and contributes to breast cancer progression through AKT signaling pathway. Molecular Carcinogenesis, 57(12), 1792–1802. https://doi.org/10.1002/mc.22897

Chicago

Liu, Yunxiao, Yanyan Dong, Liping Zhao, Lihong Su, Kexin Diao, and Xiaoyi Mi. 2018. “TRIM59 Overexpression Correlates with Poor Prognosis and Contributes to Breast Cancer Progression through AKT Signaling Pathway.” Molecular Carcinogenesis 57 (12): 1792–1802. doi:10.1002/mc.22897.